RecruitingNCT06174727

International Registry of Intra-arterial and Endosaccular Flow Diverters (IRF)

Outcomes of Intra-arterial and Endosaccular Flow Diverters for Treatment of Intracranial Aneurysms - International Registry of Intra-arterial and Endosaccular Flow Diverters (IRF)


Sponsor

Montefiore Medical Center

Enrollment

5,000 participants

Start Date

Oct 1, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

This multicenter retrospective cohort study aims to evaluate and compare the technical performance, safety, and clinical outcomes of intracranial aneurysms treated with flow diverter stents and endosaccular flow disruptors.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with intracranial aneurysm. The study is currently recruiting participants at 11 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(11)

University of Miami

Coral Gables, Florida, United States

Mayo Clinic Florida

Jacksonville, Florida, United States

Sarasota Memorial Research Institute

Sarasota, Florida, United States

Lahey Hospital and Medical Center

Burlington, Massachusetts, United States

Munson Medical Center

Traverse City, Michigan, United States

Robert Wood Johnson University

New Brunswick, New Jersey, United States

University at Buffalo

Buffalo, New York, United States

Montefiore Medical Center Department of Neurosurgery

The Bronx, New York, United States

Geisinger Health

Danville, Pennsylvania, United States

HCA Houston Healthcare Kingwood

Kingwood, Texas, United States

Toronto Western Hospital

Toronto, Ontario, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06174727


Related Trials